The abstract is read at the publisher; the summary is JClub's.
Phenylethylamine, a microbiota-associated metabolite elevated in individuals with type 2 diabetes, promotes neutrophil extracellular trap formation and delays cutaneous and oral wound healing in mice.
- Why it matters: Diabetic wound repair is impaired, but the mechanisms linking microbiota-derived metabolites to sustained inflammation are unclear.
- What they did: The study combined metabolomic and microbiome profiling in type 2 diabetes to identify phenylethylamine, then tested its effects in mouse cutaneous and oral wounds and used TAAR1 signaling and NETosis readouts.
- The result: Phenylethylamine acts via TAAR1 on neutrophils through β-arrestin–ERK–reactive oxygen species signaling; microbiota depletion lowers circulating levels, while Enterococcus faecalis recolonization increases them and worsens repair, and local TAAR1 antagonist delivery in diabetic mice reduces NETs and improves healing.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.